The new facilities of the company KINSY SOCIEDAD LIMITADA, dedicated to the manufacture of pharmaceutical active ingredients, have received a grant from the Regional Incentives aid program for the acquisition of capital goods through file MU-1577-PO2. This aid has been co-financed by the European Regional Development Fund (ERDF 2021–2027).

KINSY S.L. has increased its production capacity, achieving greater competitiveness and productivity through the incorporation of new capital goods, under file MU-1577-PO2, whose investment has been subsidized by the Regional Incentives aid program. This aid has been co-financed by the European Regional Development Fund. The project aims to expand the company’s production capacity through the implementation of new synthesis lines, with an investment of €3.89 million, addressing the demand for fine chemicals and APIs. All of this is being achieved through advanced technology and qualified personnel, which will increase production, revenue, and profitability. As a result, Kinsy will strengthen its competitiveness, consolidating its position as a benchmark in the pharmaceutical sector.